Trump administration reclassifies cannabis to Schedule III, expanding research access

bbc.com

President Trump is expected to sign an executive order reclassifying cannabis to Schedule III, a significant shift in US drug policy. This move would place cannabis in the same category as Tylenol with codeine, allowing for expanded research into its potential benefits, though it would remain federally illegal. The order could have tax implications for dispensaries and may include a pilot program for CBD reimbursement, following years of state-level legalization efforts.


With a significance score of 5.7, this news ranks in the top 0.6% of today's 31224 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: